Entity
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and sells prescription medicines, primarily focused on treating diseases like cancer.
Why it’s in the news: It is in the news due to potential merger talks with AstraZeneca and its partnerships in AI with Anthropic and NVIDIA.
Latest on Bristol Myers Squibb
- An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’
- AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
- Anthropic signs enterprise AI deal with Bristol Myers Squibb
- 13F: Pps&V Asset Management Consultants holds Bristol-Myers Squibb ($216,882)
- Wikidata: Bristol-Myers Squibb — located in — United States
- Wikidata: Bristol-Myers Squibb — operates in — pharmaceutical industry
- Wikidata: Bristol-Myers Squibb — capital ownership — Kosan Biosciences
- Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (Japan)
- Wikidata: Bristol-Myers Squibb — capital ownership — Bristol Myers Squibb (Canada)
- Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (India)
- Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (Germany)
Connections
13 entities linked to Bristol Myers Squibb across the news graph.